Effects of Mirikizumab Versus Placebo on Histologic Inflammation Evaluated by Comprehensive Assessment in 5 Intestinal Segments in a Randomized Controlled Phase 3 Trial of Participants with Crohn’s Disease
Zeitschrift für Gastroenterologie | May 13, 2025 | Volume: 63 | Issue: 05 | Pages: e360-e361
10.1055/s-0045-1809269